Huntington's Disease Research

Huntington's disease is a neurodegenerative disease characterized by cognitive decline and motor dysfunction. It is a genetic disorder which results in the production of mutant huntingtin protein (mHtt). This protein aggregates in the cell cytoplasm and nucleus, affecting cellular function.

Huntington's Disease Research Products Targets

Products for Huntington's Disease Research - Page 11

Cat.No. Product Name Information/Activity
BCN2195 Dopamine hydrochloride Dopamine HCl is a catecholamine neurotransmitter present in a wide variety of animals,And a dopamine D1-5 receptors agonist.
BCC7837 NPEC-caged-dopamine 1257326-23-0
BCC6848 SKF 38393 hydrobromide 20012-10-6
BCC7144 SKF 77434 hydrobromide 300561-58-4
BCC7071 SKF 81297 hydrobromide 67287-39-2
BCC7252 SKF 83822 hydrobromide 74115-10-9
BCC7251 SKF 83959 hydrobromide 67287-95-0
BCC7148 LE 300 274694-98-3
BCC6849 SCH 23390 hydrochloride SCH-23390 hydrochloride (R-(+)-SCH-23390 hydrochloride) is a potent and selective dopamine D1-like receptor antagonist with Kis of 0.2 nM and 0.3 nM for the D1 and D5 receptor, respectively. SCH-23390 hydrochloride is a potent and high efficacy human 5-HT2C receptor agonist with a Ki of 9.3 nM. SCH-23390 hydrochloride also binds with high affinity to the 5-HT2 and 5-HT1C receptors. SCH-23390 hydrochloride inhibits G protein-coupled inwardly rectifying potassium (GIRK) channels with an IC50 of 268 nM.
BCC7317 SCH 39166 hydrobromide 1227675-51-5